2016
$21M
from 4 investors over 4 rounds
Endogena Therapeutics, Inc. raised $21M on December 13, 2021
Investors: DEFTA Partners and Rejuveron Life Sciences AG
Endogena Therapeutics, Inc. raised $8M on January 28, 2021
Investors: DEFTA Partners and Rejuveron Life Sciences AG